menu search

LMAT / LeMaitre (LMAT) Upgraded to Strong Buy: Here's Why

LeMaitre (LMAT) Upgraded to Strong Buy: Here's Why
LeMaitre (LMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). Read More
Posted: May 31 2023, 13:01
Author Name: Zacks Investment Research
Views: 110836

LMAT News  

LeMaitre to Participate at Upcoming Investor Conferences in November

By GlobeNewsWire
November 3, 2023

LeMaitre to Participate at Upcoming Investor Conferences in November

BURLINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in th more_horizontal

LeMaitre Vascular, Inc. (LMAT) Q3 2023 Earnings Call Transcript

By Seeking Alpha
November 1, 2023

LeMaitre Vascular, Inc. (LMAT) Q3 2023 Earnings Call Transcript

LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q3 2023 Earnings Conference Call November 1, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Fin more_horizontal

PETQ or LMAT: Which Is the Better Value Stock Right Now?

By Zacks Investment Research
October 23, 2023

PETQ or LMAT: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Products sector might want to consider either PetIQ (PETQ) or LeMaitre Vascular (LMAT). But which of the more_horizontal

LeMaitre to Present at the 2023 Cantor Global Healthcare Conference

By GlobeNewsWire
September 21, 2023

LeMaitre to Present at the 2023 Cantor Global Healthcare Conference

BURLINGTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will presen more_horizontal

Looking for Dividend Growth? Buy This Little-Known Healthcare Stock

By The Motley Fool
September 1, 2023

Looking for Dividend Growth? Buy This Little-Known Healthcare Stock

LeMaitre Vascular's sales and profits surged in the second quarter. The company's dividend is supported by earnings. more_horizontal

LeMaitre: Record Quarter, ASPs And Volumes Ratcheting Higher Equals Qualified Growth Outlook

By Seeking Alpha
August 24, 2023

LeMaitre: Record Quarter, ASPs And Volumes Ratcheting Higher Equals Qualified Growth Outlook

LeMaitre Vascular's stock offers attractive long-term investment prospects, with recent consolidations offering an entry point for investors. The comp more_horizontal

LeMaitre Vascular, Inc. (LMAT) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 1, 2023

LeMaitre Vascular, Inc. (LMAT) Q2 2023 Earnings Call Transcript

LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Finan more_horizontal

LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Beat Estimates

By Zacks Investment Research
August 1, 2023

LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Beat Estimates

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares t more_horizontal


Search within

Pages Search Results: